Splisense For Profit
Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Genetic and Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable genetic illnesses and pulmonary diseases. TECHNOLOGY PIPELINE Transformative RNA-Based Treatments SpliSense is a clinical stage company developing transformative RNA-based treatments for unmet needs […]
Founded Date:
2016-01-01
Headquarters:
Jerusalem, Yerushalayim, Israel
Technology:
Disease-specific
Employee Number:
11-50
Industry:
Regenerative Medicine
Estimated Revenue:
$100K-5.0M
Number Of Exists:
N/A
Funding Status:
Seed
Investor Type:
Company
Investment Stage:
N/A